BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28409032)

  • 1. Distinct Pattern of Microgliosis in the Olfactory Bulb of Neurodegenerative Proteinopathies.
    Kohl Z; Schlachetzki JC; Feldewerth J; Hornauer P; Münch M; Adame A; Riemenschneider MJ; Winkler J; Masliah E
    Neural Plast; 2017; 2017():3851262. PubMed ID: 28409032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies.
    Wetering JV; Geut H; Bol JJ; Galis Y; Timmermans E; Twisk JWR; Hepp DH; Morella ML; Pihlstrom L; Lemstra AW; Rozemuller AJM; Jonkman LE; van de Berg WDJ
    Acta Neuropathol Commun; 2024 May; 12(1):73. PubMed ID: 38715119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-related microglia heterogeneity in the hippocampus of Alzheimer's disease, dementia with Lewy bodies, and hippocampal sclerosis of aging.
    Bachstetter AD; Van Eldik LJ; Schmitt FA; Neltner JH; Ighodaro ET; Webster SJ; Patel E; Abner EL; Kryscio RJ; Nelson PT
    Acta Neuropathol Commun; 2015 May; 3():32. PubMed ID: 26001591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased amoeboid microglial density in the olfactory bulb of Parkinson's and Alzheimer's patients.
    Doorn KJ; Goudriaan A; Blits-Huizinga C; Bol JG; Rozemuller AJ; Hoogland PV; Lucassen PJ; Drukarch B; van de Berg WD; van Dam AM
    Brain Pathol; 2014 Mar; 24(2):152-65. PubMed ID: 24033473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders.
    Mundiñano IC; Caballero MC; Ordóñez C; Hernandez M; DiCaudo C; Marcilla I; Erro ME; Tuñon MT; Luquin MR
    Acta Neuropathol; 2011 Jul; 122(1):61-74. PubMed ID: 21553300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease.
    Pey P; Pearce RK; Kalaitzakis ME; Griffin WS; Gentleman SM
    Acta Neuropathol Commun; 2014 Feb; 2():21. PubMed ID: 24528486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.
    Beach TG; White CL; Hladik CL; Sabbagh MN; Connor DJ; Shill HA; Sue LI; Sasse J; Bachalakuri J; Henry-Watson J; Akiyama H; Adler CH;
    Acta Neuropathol; 2009 Feb; 117(2):169-74. PubMed ID: 18982334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglia is associated with p-Tau aggregates in the olfactory bulb of patients with neurodegenerative diseases.
    Carmona-Abellan M; Martinez-Valbuena I; Marcilla I; DiCaudo C; Gil I; Nuñez J; Luquin MR
    Neurol Sci; 2021 Apr; 42(4):1473-1482. PubMed ID: 32816165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Beyer MK; Larsen JP; Aarsland D
    Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglial immunophenotype in dementia with Alzheimer's pathology.
    Minett T; Classey J; Matthews FE; Fahrenhold M; Taga M; Brayne C; Ince PG; Nicoll JA; Boche D;
    J Neuroinflammation; 2016 Jun; 13(1):135. PubMed ID: 27256292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients.
    Doorn KJ; Moors T; Drukarch B; van de Berg WDj; Lucassen PJ; van Dam AM
    Acta Neuropathol Commun; 2014 Aug; 2():90. PubMed ID: 25099483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease.
    Iannaccone S; Cerami C; Alessio M; Garibotto V; Panzacchi A; Olivieri S; Gelsomino G; Moresco RM; Perani D
    Parkinsonism Relat Disord; 2013 Jan; 19(1):47-52. PubMed ID: 22841687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
    Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
    Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical localization of apoptosome-related proteins in Lewy bodies in Parkinson's disease and dementia with Lewy bodies.
    Kawamoto Y; Ito H; Ayaki T; Takahashi R
    Brain Res; 2014 Jul; 1571():39-48. PubMed ID: 24835407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.
    Zelaya MV; Pérez-Valderrama E; de Morentin XM; Tuñon T; Ferrer I; Luquin MR; Fernandez-Irigoyen J; Santamaría E
    Oncotarget; 2015 Nov; 6(37):39437-56. PubMed ID: 26517091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staining of HLA-DR, Iba1 and CD68 in human microglia reveals partially overlapping expression depending on cellular morphology and pathology.
    Hendrickx DAE; van Eden CG; Schuurman KG; Hamann J; Huitinga I
    J Neuroimmunol; 2017 Aug; 309():12-22. PubMed ID: 28601280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A methodological study of locus coeruleus degeneration in dementing disorders.
    Haglund M; Friberg N; Danielsson EJ; Norrman J; Englund E
    Clin Neuropathol; 2016; 35(5):287-94. PubMed ID: 27191912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglial activation occurs late during preclinical Alzheimer's disease.
    Streit WJ; Braak H; Del Tredici K; Leyh J; Lier J; Khoshbouei H; Eisenlöffel C; Müller W; Bechmann I
    Glia; 2018 Dec; 66(12):2550-2562. PubMed ID: 30417428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.